147 related articles for article (PubMed ID: 26646751)
21. The influence of hydrocortisone substitution on the quality of life and parameters of bone metabolism in patients with secondary hypocortisolism.
Wichers M; Springer W; Bidlingmaier F; Klingmüller D
Clin Endocrinol (Oxf); 1999 Jun; 50(6):759-65. PubMed ID: 10468948
[TBL] [Abstract][Full Text] [Related]
22. A randomized-controlled trial of prophylactic hydrocortisone supplementation for the prevention of hypotension in extremely low birth weight infants.
Efird MM; Heerens AT; Gordon PV; Bose CL; Young DA
J Perinatol; 2005 Feb; 25(2):119-24. PubMed ID: 15329742
[TBL] [Abstract][Full Text] [Related]
23. Achieving a physiological cortisol profile with once-daily dual-release hydrocortisone: a pharmacokinetic study.
Johannsson G; Lennernäs H; Marelli C; Rockich K; Skrtic S
Eur J Endocrinol; 2016 Jul; 175(1):85-93. PubMed ID: 27129362
[TBL] [Abstract][Full Text] [Related]
24. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
[TBL] [Abstract][Full Text] [Related]
25. Switching From Immediate-Release to Fractionated Dual-Release Hydrocortisone May Improve Metabolic Control and QoL in Selected Primary Adrenal Insufficiency Patients.
Delle Cese F; Corsello A; Cintoni M; Locantore P; Pontecorvi A; Corsello SM; Paragliola RM
Front Endocrinol (Lausanne); 2020; 11():610904. PubMed ID: 33597926
[TBL] [Abstract][Full Text] [Related]
26. Association between adrenal insufficiency and ventilator weaning.
Huang CJ; Lin HC
Am J Respir Crit Care Med; 2006 Feb; 173(3):276-80. PubMed ID: 16272449
[TBL] [Abstract][Full Text] [Related]
27. Cardiometabolic and psychological effects of dual-release hydrocortisone: a cross-over study.
Dineen R; Martin-Grace J; Ahmed KMS; Frizelle I; Gunness A; Garrahy A; Hannon AM; O'Reilly MW; Smith D; McDermott J; Healy ML; Agha A; Pazderska A; Gibney J; Thompson CJ; Behan LA; Sherlock M
Eur J Endocrinol; 2021 Feb; 184(2):253-265. PubMed ID: 33513125
[TBL] [Abstract][Full Text] [Related]
28. Psychological morbidity and impaired quality of life in patients with stable treatment for primary adrenal insufficiency: cross-sectional study and review of the literature.
Tiemensma J; Andela CD; Kaptein AA; Romijn JA; van der Mast RC; Biermasz NR; Pereira AM
Eur J Endocrinol; 2014 Aug; 171(2):171-82. PubMed ID: 24801589
[TBL] [Abstract][Full Text] [Related]
29. Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisone.
Small EJ; Meyer M; Marshall ME; Reyno LM; Meyers FJ; Natale RB; Lenehan PF; Chen L; Slichenmyer WJ; Eisenberger M
J Clin Oncol; 2000 Apr; 18(7):1440-50. PubMed ID: 10735891
[TBL] [Abstract][Full Text] [Related]
30. [Results of the French cohort of the European observational study FINDER: quality of life of patients treated with antidepressants].
Dantchev N; Tcherny-Lessenot S; Picard H; Baraille L; Quail D
Encephale; 2013 Apr; 39(2):101-8. PubMed ID: 23095580
[TBL] [Abstract][Full Text] [Related]
31. Corticosteroid after etomidate in critically ill patients: a randomized controlled trial.
Payen JF; Dupuis C; Trouve-Buisson T; Vinclair M; Broux C; Bouzat P; Genty C; Monneret D; Faure P; Chabre O; Bosson JL
Crit Care Med; 2012 Jan; 40(1):29-35. PubMed ID: 21926601
[TBL] [Abstract][Full Text] [Related]
32. Hydrocortisone and fludrocortisone for prevention of hospital-acquired pneumonia in patients with severe traumatic brain injury (Corti-TC): a double-blind, multicentre phase 3, randomised placebo-controlled trial.
Asehnoune K; Seguin P; Allary J; Feuillet F; Lasocki S; Cook F; Floch H; Chabanne R; Geeraerts T; Roger C; Perrigault PF; Hanouz JL; Lukaszewicz AC; Biais M; Boucheix P; Dahyot-Fizelier C; Capdevila X; Mahe PJ; Le Maguet P; Paugam-Burtz C; Gergaud S; Plaud B; Constantin JM; Malledant Y; Flet L; Sebille V; Roquilly A;
Lancet Respir Med; 2014 Sep; 2(9):706-16. PubMed ID: 25066331
[TBL] [Abstract][Full Text] [Related]
33. Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial.
Stockler MR; O'Connell R; Nowak AK; Goldstein D; Turner J; Wilcken NR; Wyld D; Abdi EA; Glasgow A; Beale PJ; Jefford M; Dhillon H; Heritier S; Carter C; Hickie IB; Simes RJ;
Lancet Oncol; 2007 Jul; 8(7):603-12. PubMed ID: 17548243
[TBL] [Abstract][Full Text] [Related]
34. Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial.
Heutte N; Flechtner HH; Mounier N; Mellink WA; Meerwaldt JH; Eghbali H; van't Veer MB; Noordijk EM; Kluin-Nelemans JC; Lampka E; Thomas J; Lugtenburg PJ; Viterbo L; Carde P; Hagenbeek A; van der Maazen RW; Smit WG; Brice P; van Marwijk Kooy M; Baars JW; Poortmans P; Tirelli U; Leeksma OC; Tomsic R; Feugier P; Salles G; Gabarre J; Kersten MJ; Van Den Neste E; Creemers GJ; Gaillard I; Meijnders P; Tertian G; Reman O; Muller HP; Troncy J; Blanc M; Schroyens W; Voogt PJ; Wijermans P; Rieux C; Fermé C; Henry-Amar M;
Lancet Oncol; 2009 Dec; 10(12):1160-70. PubMed ID: 19828373
[TBL] [Abstract][Full Text] [Related]
35. Management of glucocorticoid replacement in adrenal insufficiency shows notable heterogeneity - data from the EU-AIR.
Murray RD; Ekman B; Uddin S; Marelli C; Quinkler M; Zelissen PM;
Clin Endocrinol (Oxf); 2017 Mar; 86(3):340-346. PubMed ID: 27801983
[TBL] [Abstract][Full Text] [Related]
36. Usefulness of Time-Point Serum Cortisol and ACTH Measurements for the Adjustment of Glucocorticoid Replacement in Adrenal Insufficiency.
Rousseau E; Joubert M; Trzepla G; Parienti JJ; Freret T; Vanthygem MC; Desailloud R; Lefebvre H; Coquerel A; Reznik Y;
PLoS One; 2015; 10(8):e0135975. PubMed ID: 26317782
[TBL] [Abstract][Full Text] [Related]
37. PlenadrEMA: effect of dual-release versus conventional hydrocortisone on fatigue, measured by ecological momentary assessments: a study protocol for an open-label switch pilot study.
Boesen VB; Christoffersen T; Watt T; Borresen SW; Klose M; Feldt-Rasmussen U
BMJ Open; 2018 Jan; 8(1):e019487. PubMed ID: 29362269
[TBL] [Abstract][Full Text] [Related]
38. Steroid use for refractory hypotension in congenital diaphragmatic hernia.
Robertson JO; Criss CN; Hsieh LB; Matsuko N; Gish JS; Mon RA; Johnson KN; Gadepalli SK
Pediatr Surg Int; 2017 Sep; 33(9):981-987. PubMed ID: 28685301
[TBL] [Abstract][Full Text] [Related]
39. Quality of life in patients with adrenal insufficiency correlates stronger with hydrocortisone dosage, than with long-term systemic cortisol levels.
Andela CD; Staufenbiel SM; Joustra SD; Pereira AM; van Rossum EF; Biermasz NR
Psychoneuroendocrinology; 2016 Oct; 72():80-6. PubMed ID: 27388687
[TBL] [Abstract][Full Text] [Related]
40. Dual-release hydrocortisone and its benefits on cognitive function and quality of sleep.
Krekeler C; Kropp P; Blacha AK; Rahvar AH; Harbeck B
Endocrine; 2021 Apr; 72(1):223-233. PubMed ID: 33625720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
